Page last updated: 2024-09-03

imatinib mesylate and Basophilic Leukemia, Acute

imatinib mesylate has been researched along with Basophilic Leukemia, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapelushnik, J; Manor, E; Moser, AM; Narkis, G1

Other Studies

1 other study(ies) available for imatinib mesylate and Basophilic Leukemia, Acute

ArticleYear
Imatinib resistant chronic myelogenous leukemia, BCR-ABL positive by chromosome and FISH analyses but negative by PCR, in a child progressing to acute basophilic leukemia: cytogenetic follow-up.
    Cancer genetics and cytogenetics, 2006, Oct-01, Volume: 170, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Bone Marrow Transplantation; Child; Disease Progression; Drug Resistance, Neoplasm; Genes, abl; Humans; Imatinib Mesylate; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia, Basophilic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction

2006